Amylyx Pharmaceuticals, Inc.

EASTERN BANK AMLX
Report date
6/30/2026
Quarter
2026 Q2
Filed
7/1/2026
Shares
721
Value ($000)
13
Weight
0.0%
2026 Q1 - 2026 Q2 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).